Sagent LLC, a global provider of network equipment, repair and maintenance services, has appointed Bill Tart as its Chief Executive Officer. With over 30 years of experience in the Private Sector and US Military, Mr. Tart has designed, implemented and overseen both manufacturing and service offerings across a wide range of technologies.

Prior to joining Sagent, Mr. Tart served in various executive roles at DynCorp International and ASRC Federal, and most recently, was President and COO of Draken International. Prior to these roles, Mr Tart completed a 25-year US Air Force career spanning flying duties as an electronic warfare officer and later a UAV pilot, to staff duties including legislative affairs, Secretary of the Air Force speechwriter, and campaign strategist. He commanded hundreds of Airmen flying in combat and pioneered the way the US and her Allies approach the use of unmanned aircraft.

Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the election of Leslie Teso-Lichtman to its Board of Directors at Chembio’s 2022 Annual Meeting of Stockholders.

“We are excited to have Leslie join the Chembio Board of Directors,” said Richard Eberly, Chembio’s Chief Executive Officer and President. “Her significant experience in corporate financial leadership at global diagnostics companies will be an important asset as we strive to create value through our Global Competitiveness program by leveraging Chembio’s broad product portfolio and operations worldwide.”

Ms. Teso-Lichtman serves as Senior Vice President and Chief Financial Officer of CereVasc, Inc., where she is responsible for the accounting, finance, and treasury functions, including forecasting and capital planning. Previously, Ms. Teso-Lichtman served as Senior Vice President of Finance and Treasurer for Roche Diagnostics Hematology from 2011 to 2014, following Roche’s acquisition of her former employer Constitutional Medical Investors, Inc. Ms. Teso-Lichtman worked on the integration plan for the new company and to achieve milestones in connection with the acquisition. Prior to her time at Constitutional Medical, Ms. Teso-Lichtman held the role of Vice President and Controller at Cytyc Corporation, which was acquired by Hologic, Inc. in 2007, where she was responsible for all finance and accounting activities, including completing three acquisitions.